Stock Events

Stock Events

Revelation Biosciences

0

0

+€0.00+0% 00:00 Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

7AugExpected

Q1 2026

Next

-2.31

-1.78

-1.25

-0.73

Expected EPS

-0.725503

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 56U1.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Moderna is a leader in mRNA technology, competing in the biotech space with innovative treatments and vaccines that could overlap with Revelation Biosciences' therapeutic areas.

BioNTech competes in the development of novel therapies and vaccines, directly challenging Revelation Biosciences in the innovative biopharmaceutical market.

Novavax is involved in the development of vaccines for infectious diseases, competing with Revelation Biosciences in the vaccine development space.

Pfizer is a large pharmaceutical company with a broad product portfolio that includes vaccines and therapies, competing across several of Revelation Biosciences' potential markets.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical division Janssen, competes in the development of drugs and vaccines, covering areas that Revelation Biosciences may target.

Gilead Sciences

Gilead Sciences is known for its antiviral drugs, directly competing with Revelation Biosciences in the development of treatments for infectious diseases.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals competes in the biotechnology field, focusing on immunology and infectious diseases, areas of interest for Revelation Biosciences.

Vertex Pharmaceuticals

Vertex Pharmaceuticals focuses on creating new treatments for serious diseases, potentially competing with Revelation Biosciences in drug development and innovation.

Amgen is a biotech firm that develops innovative medicines, including for immune disorders, competing with Revelation Biosciences in the biopharmaceutical sector.

AstraZeneca is a global pharmaceutical company that develops vaccines and treatments for various diseases, competing with Revelation Biosciences in several therapeutic areas.

About

Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute kidney injury, and GEM-CKD, intended for the prevention and treatment of chronic kidney disease. Established in 2019, this San Diego, California-based enterprise was formerly known as Petra Acquisition, Inc., before officially adopting the name Revelation Biosciences, Inc. in January 2022.

Show more...

CEO

Mr. James M. Rolke

Employees

8

Country

United States

ISIN

US76135L3096

Listings

0 Comments

Share your thoughts

FAQ

What is Revelation Biosciences stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Revelation Biosciences stocks are traded under the ticker 56U1.STU.

When is the next Revelation Biosciences earnings date?▼

Revelation Biosciences is going to release the next earnings report on August 07, 2026.

What were Revelation Biosciences earnings last quarter?▼

56U1.STU earnings for the last quarter are -2.31 EUR per share, whereas the estimation was -2.31 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.

How many employees does Revelation Biosciences have?▼

As of July 18, 2026, the company has 8 employees.

In which sector is Revelation Biosciences located?▼

Revelation Biosciences operates in the Health & Wellness sector.

When did Revelation Biosciences complete a stock split?▼

Revelation Biosciences has not had any recent stock splits.

Where is Revelation Biosciences headquartered?▼

Revelation Biosciences is headquartered in San Diego, United States.